Recent News

• 05.07.2026 - MediWound to Report First Quarter 2026 Financial Results
• 04.15.2026 - Newly Published U.S. Expert Consensus Aligns with MediWound’s Strategy for Chronic Wound Debridement
• 04.02.2026 - MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
• 04.02.2026 - MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million

Recent Filings

• 05.06.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.02.2026 - EX-99.1 EX-99.1
• 04.02.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 03.30.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 03.30.2026 - EX-99.1 EX-99.1
• 03.25.2026 - 3 Initial statement of beneficial ownership of securities
• 03.18.2026 - 3 Initial statement of beneficial ownership of securities
• 03.18.2026 - 3 Initial statement of beneficial ownership of securities
• 03.18.2026 - 3 Initial statement of beneficial ownership of securities
• 03.18.2026 - 3 Initial statement of beneficial ownership of securities